An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
Public ClinicalTrials.gov record NCT04950114. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label Phase 2 study evaluating the long term safety and tolerability of GFB-887 in patients with focal segmental glomerulosclerosis (FSGS), and treatment-resistant minimal change disease (TR-MCD)
Study identification
- NCT ID
- NCT04950114
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 31 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2021 (Actual)
- Primary completion
- Nov 2, 2022 (Actual)
- Completion
- Nov 2, 2022 (Actual)
- Last update posted
- Nov 15, 2022
2021 – 2022
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Academic Medical Research Institute (AMRI) | Los Angeles | California | 90022 | — |
| Amicis Research Center | Northridge | California | 91324 | — |
| Kidney and Hypertension Center - Apple Valley | Victorville | California | 92395 | — |
| University of Colorado Anschutz Medical Center | Aurora | Colorado | 80045 | — |
| Colorado Kidney Care (Denver Nephrology) | Denver | Colorado | 80230 | — |
| Boise Kidney and Hypertension Institute | Nampa | Idaho | 83687 | — |
| NANI Research, LLC | Hinsdale | Illinois | 60521 | — |
| St. Clair Nephrology | Roseville | Michigan | 48066 | — |
| Clinical Research Consultants | Kansas City | Missouri | 64111 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Southeast Renal Research Institute | Chattanooga | Tennessee | 37404-2743 | — |
| Prolato Clinical Research Center | Houston | Texas | 77054 | — |
| Clinical Advancement Center, PLLC | San Antonio | Texas | 78212 | — |
| Tranquility Research | Webster | Texas | 77598 | — |
| Utah Kidney Center | Salt Lake City | Utah | 84115 | — |
| Providence Medical Research Center | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04950114, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2022 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04950114 live on ClinicalTrials.gov.